Several studies showed that EGFR mutation patterns in NSCLC primary lesions and metastases in various body locations are not consistent with that found in the BMs (24–26), possibly because of the specific events required for cancer cell migration to and survival in the brain. The gene discussed is EGFR; the disease is cancer.